Mirador Lands $400m To Pursue I&I Precision Medicine Approach

 
• By Joseph Haas

Ex-Prometheus team will use its big data platform to validate targets, select indications and optimize trial enrollment in the development of precision therapies for inflammatory and immune disorders.

Vantage point
Mirador expects a unique vantage point to address IBD indications • Source: Shutterstock

More from Financing

More from Business